Featured Posts
Nomic and Broad Clinical Labs partner to unlock broader applications for proteomics through high-plex, quantitative data that enables cross-study comparable insights. MONTREAL–(BUSINESS WIRE)–Nomic Bio today announced a partnership with...Read More
The National Multi-Omics Accelerator: How Broad Clinical Labs Provides Inclusive Access to Translational Science and Technology For three decades, the genomics field has refined the science and methodology of sequencing....Read More
From Bench to Clinical Scale: Broad Clinical Labs’ Approach to Scaling a Custom Assay Translating a high-performing custom benchtop assay into a reliable, clinical-grade operation at scale is technically challenging....Read More
The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale over existing data available in...Read More
Short-Read vs. Long-Read WGS: Which is Right for Your Next Project? Key Takeaways: Your sequencing strategy decision impacts downstream analysis and research outcomes Short-read sequencing enables cost-efficient analysis of...Read More
At Broad Clinical Labs (BCL), the expertise behind our operations is powered by dedicated professionals who ensure that our science is accurate, reliable, and ready to make a real impact....Read More
BOSTON, MA — October 15, 2025 — Broad Clinical Labs (BCL), in collaboration with Roche Sequencing Solutions and Boston Children’s Hospital, today announced official recognition by Guinness World Records for...Read More
At Broad Clinical Labs (BCL), the journey from an idea to a working product often involves people who bridge science, technology, and customer needs. One of those people is Matthew...Read More
At Broad Clinical Labs (BCL), our people are at the core of everything we do. Their expertise and dedication are what make it possible to advance cutting-edge science and deliver...Read More
Mass General Brigham Launches Genetic Test to Predict Risk Across Eight Cardiovascular Conditions Boston, MA – September 3,2025 — In a step forward for genomic-driven preventive medicine, Mass General Brigham...Read More
Nomic and Broad Clinical Labs partner to unlock broader applications for proteomics through high-plex, quantitative data that enables cross-study comparable insights. MONTREAL–(BUSINESS WIRE)–Nomic Bio today announced a partnership...
The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale over existing data available...
Mass General Brigham Launches Genetic Test to Predict Risk Across Eight Cardiovascular Conditions Boston, MA – September 3,2025 — In a step forward for genomic-driven preventive medicine, Mass General...
In a pioneering collaboration aimed at transforming pediatric cancer diagnostics and research, Boston Children’s Hospital, Dana-Farber Cancer Institute, and Broad Clinical Labs have announced the formation of BrightSeq—Boston Research...
Everygene, a precision health company dedicated to expanding access to genetic insights for families affected by inherited disease, today announced the launch of a nationwide, no-cost genetic testing program...
Galatea Bio and Fabric Genomics, a GeneDx company, announced a strategic collaboration to enhance genetic testing by incorporating both rare pathogenic variant analysis and polygenic risk scoring (PRS) to...